Moderna’s Cancer Vaccine Could Change America in 7 Surprising Ways

If ongoing studies in other cancers produce similar results, the technology could influence far more than cancer care itself.

Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.

The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.

New cancer vaccine could change how doctors fight deadly melanoma, expert says

Dr. Murad Alam, chief of dermatology at Northwestern Medicine in Chicago, shares the significance of Merck and Moderna's ...

Moderna's cancer vaccine hits key goal in melanoma trial with NYU Langone link

Moderna shares jumped this week after the company announced encouraging results from a late-stage melanoma trial.

Cleveland team develops cancer vaccine using COVID immunity

University Hospitals and Celloram are advancing Protexi, a platform that redirects antiviral immune memory from COVID-19 ...
C&EN

In a first, an mRNA cancer vaccine succeeds in late-stage clinical trial

Moderna’s vaccine, intismeran, is a personalized neoantigen vaccine. It delivers mRNA that encodes tumor-specific mutations ...

Skin cancer vaccine slashes risk of dying from the disease - giving hope to thousands

Scientists have hailed the development of the melanoma jab as a 'pivotal moment' in the fight against the deadly disease - ...

Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program

EVX-05 is an off-the-shelf therapeutic glioblastoma (brain cancer) vaccine designed based on patient tumor samples. It targets novel conserved antigens identified using Evaxion’s AI-Immunology™ ...